胶质瘤中的细胞衰老
本文综述胶质瘤中细胞衰老的诱导、绕过与逃逸机制,阐述衰老细胞通过衰老相关分泌表型(SASP)在肿瘤微环境中发挥促肿瘤作用,并探讨其与肿瘤复发进展及靶向衰老的治疗机会。
要点
- 放疗和替莫唑胺化疗均可诱导胶质瘤细胞衰老。
- 胶质瘤可通过多种机制绕过或逃逸衰老并保持增殖。
- 衰老细胞存活并分泌SASP, paradoxically 具有促肿瘤效应,可能参与复发。
核心结论
- 本文概述了胶质瘤中衰老的诱导、绕过和逃逸机制,并探讨了衰老细胞在肿瘤微环境、进展和复发中的作用及靶向衰老的潜在治疗机会。
研究设计与样本
- 综述类文章,检索范围原文未报告。
主要发现
- 胶质瘤的标准治疗通常包括放疗和以替莫唑胺为基础的化疗,两者均诱导细胞衰老这一肿瘤抑制机制。
- 胶质瘤采用多种机制绕过或逃逸衰老并保持增殖状态。
- 衰老细胞保持存活并分泌大量统称为衰老相关分泌表型(SASP)的因子,这些因子矛盾地也具有促肿瘤效应。
- 衰老细胞可能代表一种肿瘤休眠形式,并在胶质瘤复发和进展中发挥作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Glioma is the most common primary brain tumor and is often associated with treatment resistance and poor prognosis. Standard treatment typically involves radiotherapy and temozolomide-based chemotherapy, both of which induce cellular senescence-a tumor suppression mechanism. DISCUSSION: Gliomas employ various mechanisms to bypass or escape senescence and remain in a proliferative state. Importantly, senescent cells remain viable and secrete a large number of factors collectively known as the senescence-associated secretory phenotype (SASP) that, paradoxically, also have pro-tumorigenic effects. Furthermore, senescent cells may represent one form of tumor dormancy and play a role in glioma recurrence and progression. CONCLUSION: In this article, we delineate an overview of senescence in the context of gliomas, including the mechanisms that lead to senescence induction, bypass, and escape. Furthermore, we examine the role of senescent cells in the tumor microenvironment and their role in tumor progression and recurrence. Additionally, we highlight potential therapeutic opportunities for targeting senescence in glioma.
引用
- Chojak R, Fares J, Petrosyan E, et al. Cellular senescence in glioma. J Neurooncol. 2023. PMID: 37458855. doi:10.1007/s11060-023-04387-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。